Moving Forward at the 26th Congress of the Polish Huntington Association – Written by the Moving Forward Team on May 17th 2022 In April 2022,…
Another Vibrant Possibility for Huntington’s Disease Treatment: Novartis Branaplam Written by the Moving Forward Team on March 17th2022 Novartis Pharmaceuticals is recruiting participants for their…
THE UNCERTAINTY OF WAITING First informal meeting of pre-symptomatic or possible carriers of Huntington’s Disease in Spain Written by the Moving Forward Team on March…
Updates about Roche GENERATION-HD1 and Tominersen It’s not over until it’s over Written by the Moving Forward Team on February 3rd 2022 The pharmaceutical company…
EFFECTIVE COMMUNICATION IS THE KEY TO SUCCESSFUL WORK MOVING FORWARD PROMOTES AN ONLINE TRAINING COURSE FOR HEALTHCARE PROFESSIONALS IN RUSSIA Written by the Moving Forward…
Getting back to normal! The first Moving Forward face-to-face meeting after Covid! Written by the Moving Forward Team on November 29th2021 The landing of Moving…
Moving Forward travels to the Balearic Islands! We met up with the Balearic HD Association Written by the Moving Forward Team on November 26th2021 As…
Moving Forward Survey in Spain Written by the Moving Forward Team on November 14th 2021 The project Moving Forward is starting in Spain and we…
Moving Forward featured on the November issue of the EHDN Newsletter Written by the Moving Forward Team on November 12th 2022 Our project made it to…
Moving Forward in Spain Written by the Moving Forward Team on November 3rd 2021 The European Huntington’s Association welcomes Spain as a new addition to its…